Gerald Dodd
Concepts (374)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiology | 15 | 2017 | 196 | 5.010 |
Why?
| Catheter Ablation | 28 | 2016 | 291 | 3.620 |
Why?
| Liver Neoplasms | 33 | 2012 | 521 | 2.240 |
Why?
| Liver | 29 | 2016 | 1690 | 2.120 |
Why?
| Portal Vein | 12 | 2016 | 81 | 2.040 |
Why?
| Tomography, X-Ray Computed | 51 | 2015 | 2392 | 1.750 |
Why?
| Carcinoma, Hepatocellular | 16 | 2005 | 224 | 1.300 |
Why?
| Diagnostic Imaging | 8 | 2017 | 296 | 1.270 |
Why?
| Liver Cirrhosis | 17 | 2003 | 238 | 1.160 |
Why?
| Blood Flow Velocity | 6 | 2016 | 324 | 1.130 |
Why?
| Microwaves | 6 | 2015 | 32 | 1.080 |
Why?
| Hepatectomy | 4 | 2016 | 137 | 1.050 |
Why?
| Liver Circulation | 7 | 2016 | 21 | 1.020 |
Why?
| Societies, Medical | 4 | 2013 | 684 | 1.010 |
Why?
| Models, Organizational | 3 | 2016 | 143 | 0.970 |
Why?
| Students, Medical | 2 | 2017 | 277 | 0.760 |
Why?
| Organizational Objectives | 3 | 2015 | 71 | 0.700 |
Why?
| Computer-Assisted Instruction | 2 | 2013 | 64 | 0.680 |
Why?
| Delivery of Health Care | 2 | 2016 | 844 | 0.640 |
Why?
| Internship and Residency | 4 | 2013 | 951 | 0.630 |
Why?
| Internet | 2 | 2013 | 602 | 0.630 |
Why?
| Radiology Information Systems | 1 | 2016 | 30 | 0.540 |
Why?
| Biotechnology | 1 | 2016 | 46 | 0.530 |
Why?
| Laboratories | 1 | 2017 | 95 | 0.530 |
Why?
| Contrast Media | 12 | 2015 | 362 | 0.530 |
Why?
| Fasciola hepatica | 1 | 2015 | 5 | 0.530 |
Why?
| Fascioliasis | 1 | 2015 | 7 | 0.520 |
Why?
| Organizational Innovation | 1 | 2016 | 132 | 0.510 |
Why?
| Cattle | 8 | 2016 | 935 | 0.500 |
Why?
| Personal Satisfaction | 1 | 2017 | 185 | 0.500 |
Why?
| Private Sector | 1 | 2015 | 51 | 0.490 |
Why?
| Prostate | 1 | 2015 | 157 | 0.480 |
Why?
| Radiology Department, Hospital | 1 | 2014 | 18 | 0.460 |
Why?
| Health Care Reform | 1 | 2015 | 92 | 0.460 |
Why?
| Curriculum | 3 | 2017 | 852 | 0.460 |
Why?
| Editorial Policies | 1 | 2014 | 44 | 0.450 |
Why?
| Biological Science Disciplines | 1 | 2013 | 16 | 0.450 |
Why?
| Education, Medical | 2 | 2014 | 225 | 0.450 |
Why?
| Education, Graduate | 1 | 2013 | 32 | 0.450 |
Why?
| Hepatic Veins | 4 | 2000 | 31 | 0.440 |
Why?
| Program Evaluation | 2 | 2017 | 836 | 0.430 |
Why?
| Computers, Handheld | 1 | 2013 | 24 | 0.430 |
Why?
| Schools, Medical | 1 | 2014 | 123 | 0.430 |
Why?
| Advisory Committees | 1 | 2014 | 208 | 0.430 |
Why?
| Publishing | 1 | 2014 | 127 | 0.420 |
Why?
| Hemangioma, Cavernous | 1 | 2012 | 15 | 0.420 |
Why?
| Periodicals as Topic | 1 | 2014 | 183 | 0.400 |
Why?
| International Cooperation | 1 | 2012 | 174 | 0.390 |
Why?
| Efficiency, Organizational | 2 | 2015 | 126 | 0.380 |
Why?
| Mobile Applications | 1 | 2013 | 140 | 0.370 |
Why?
| United States | 12 | 2016 | 12295 | 0.370 |
Why?
| Ultrasonography | 18 | 2013 | 641 | 0.360 |
Why?
| Thrombosis | 6 | 1997 | 302 | 0.360 |
Why?
| Societies, Scientific | 1 | 2010 | 47 | 0.360 |
Why?
| Research Support as Topic | 2 | 2010 | 108 | 0.360 |
Why?
| Ultrasonography, Interventional | 4 | 1999 | 125 | 0.360 |
Why?
| Education | 1 | 2010 | 99 | 0.350 |
Why?
| Magnetic Resonance Imaging | 14 | 2013 | 3069 | 0.350 |
Why?
| Cooperative Behavior | 1 | 2012 | 390 | 0.340 |
Why?
| Portasystemic Shunt, Transjugular Intrahepatic | 3 | 2000 | 39 | 0.340 |
Why?
| Minimally Invasive Surgical Procedures | 2 | 2001 | 154 | 0.330 |
Why?
| Sensitivity and Specificity | 14 | 2016 | 1718 | 0.330 |
Why?
| Middle Aged | 52 | 2015 | 26999 | 0.320 |
Why?
| Diverticulitis, Colonic | 2 | 1999 | 7 | 0.320 |
Why?
| Colonic Neoplasms | 3 | 2004 | 222 | 0.320 |
Why?
| Cholelithiasis | 2 | 1999 | 31 | 0.310 |
Why?
| Humans | 93 | 2017 | 115587 | 0.300 |
Why?
| Research | 2 | 2010 | 396 | 0.300 |
Why?
| In Vitro Techniques | 5 | 2016 | 1044 | 0.290 |
Why?
| Cholangitis, Sclerosing | 2 | 1999 | 74 | 0.290 |
Why?
| Imaging, Three-Dimensional | 4 | 2016 | 495 | 0.290 |
Why?
| Hepatic Artery | 3 | 1996 | 52 | 0.280 |
Why?
| Terminology as Topic | 4 | 2014 | 186 | 0.280 |
Why?
| Cryosurgery | 2 | 2004 | 52 | 0.270 |
Why?
| Lymph Nodes | 3 | 1997 | 423 | 0.270 |
Why?
| Postoperative Complications | 7 | 2005 | 2161 | 0.270 |
Why?
| Videoconferencing | 1 | 2006 | 57 | 0.270 |
Why?
| Neoplasms | 7 | 2014 | 2118 | 0.270 |
Why?
| Lipoma | 3 | 1990 | 16 | 0.270 |
Why?
| Liver Transplantation | 6 | 1996 | 830 | 0.260 |
Why?
| Leiomyoma | 3 | 1990 | 45 | 0.260 |
Why?
| Aged | 35 | 2015 | 19251 | 0.250 |
Why?
| Female | 55 | 2017 | 59913 | 0.240 |
Why?
| Electrocoagulation | 2 | 2001 | 38 | 0.240 |
Why?
| Teaching | 1 | 2006 | 224 | 0.240 |
Why?
| History, 21st Century | 2 | 2016 | 162 | 0.230 |
Why?
| History, 20th Century | 2 | 2016 | 273 | 0.220 |
Why?
| Cholangiography | 2 | 2000 | 16 | 0.210 |
Why?
| Perfusion | 3 | 2012 | 150 | 0.210 |
Why?
| Phantoms, Imaging | 2 | 2014 | 134 | 0.210 |
Why?
| Computer Simulation | 2 | 2010 | 881 | 0.210 |
Why?
| Male | 52 | 2017 | 55949 | 0.200 |
Why?
| Forecasting | 2 | 2014 | 333 | 0.200 |
Why?
| Electric Injuries | 1 | 2001 | 1 | 0.200 |
Why?
| Head and Neck Neoplasms | 3 | 2011 | 425 | 0.200 |
Why?
| Animals | 14 | 2016 | 32102 | 0.200 |
Why?
| Adult | 35 | 2017 | 30718 | 0.190 |
Why?
| Information Dissemination | 2 | 2014 | 193 | 0.190 |
Why?
| Ultrasonography, Doppler, Duplex | 3 | 1995 | 39 | 0.190 |
Why?
| Carcinoma, Squamous Cell | 3 | 2011 | 577 | 0.180 |
Why?
| Cystadenocarcinoma, Papillary | 1 | 2000 | 5 | 0.180 |
Why?
| Iopanoic Acid | 1 | 2000 | 1 | 0.180 |
Why?
| Kidney Transplantation | 5 | 1993 | 558 | 0.180 |
Why?
| Congresses as Topic | 2 | 2013 | 204 | 0.180 |
Why?
| Ultrasonography, Doppler, Color | 2 | 2016 | 33 | 0.170 |
Why?
| Peritoneal Neoplasms | 1 | 2000 | 54 | 0.170 |
Why?
| Radiography | 6 | 2012 | 826 | 0.170 |
Why?
| Chemoembolization, Therapeutic | 1 | 2000 | 49 | 0.170 |
Why?
| Uterine Neoplasms | 2 | 1990 | 73 | 0.170 |
Why?
| Doxorubicin | 2 | 2011 | 290 | 0.170 |
Why?
| Equipment Design | 3 | 2016 | 517 | 0.170 |
Why?
| Liver Cirrhosis, Biliary | 1 | 1999 | 18 | 0.170 |
Why?
| Radiography, Interventional | 2 | 2014 | 111 | 0.160 |
Why?
| Image Processing, Computer-Assisted | 7 | 2008 | 691 | 0.150 |
Why?
| Radiography, Abdominal | 2 | 1999 | 33 | 0.150 |
Why?
| Arterial Occlusive Diseases | 2 | 1996 | 73 | 0.150 |
Why?
| Radiation Exposure | 1 | 2017 | 41 | 0.150 |
Why?
| Intergenerational Relations | 1 | 2017 | 15 | 0.140 |
Why?
| Prospective Studies | 11 | 2005 | 6264 | 0.140 |
Why?
| Renal Artery Obstruction | 3 | 1995 | 30 | 0.140 |
Why?
| Ovarian Neoplasms | 3 | 1990 | 407 | 0.140 |
Why?
| Hemangioma | 1 | 1997 | 41 | 0.140 |
Why?
| Inventions | 1 | 2016 | 17 | 0.140 |
Why?
| Infarction | 1 | 1996 | 12 | 0.140 |
Why?
| Models, Anatomic | 1 | 2016 | 92 | 0.130 |
Why?
| Equipment Failure Analysis | 1 | 2016 | 135 | 0.130 |
Why?
| Biopsy, Needle | 5 | 1996 | 183 | 0.130 |
Why?
| alpha-Fetoproteins | 1 | 1996 | 32 | 0.130 |
Why?
| Treatment Outcome | 6 | 2016 | 9159 | 0.130 |
Why?
| Organ Size | 1 | 2016 | 434 | 0.130 |
Why?
| Hepatic Veno-Occlusive Disease | 1 | 1995 | 10 | 0.130 |
Why?
| Portasystemic Shunt, Surgical | 1 | 1995 | 7 | 0.130 |
Why?
| Texas | 2 | 2013 | 187 | 0.130 |
Why?
| Ultrasonography, Doppler | 1 | 1995 | 105 | 0.120 |
Why?
| Awards and Prizes | 1 | 2016 | 56 | 0.120 |
Why?
| Program Development | 1 | 2017 | 350 | 0.120 |
Why?
| Constriction, Pathologic | 4 | 1996 | 210 | 0.120 |
Why?
| Radiology, Interventional | 1 | 2014 | 28 | 0.120 |
Why?
| Research Design | 2 | 2014 | 946 | 0.120 |
Why?
| Education, Medical, Undergraduate | 1 | 2017 | 174 | 0.120 |
Why?
| Ablation Techniques | 1 | 2014 | 29 | 0.120 |
Why?
| Reproducibility of Results | 4 | 2016 | 2800 | 0.120 |
Why?
| Bile Duct Diseases | 1 | 1994 | 17 | 0.120 |
Why?
| Neoplasm Invasiveness | 1 | 1995 | 445 | 0.120 |
Why?
| Time Factors | 10 | 2015 | 6165 | 0.120 |
Why?
| Angiography | 3 | 2000 | 177 | 0.110 |
Why?
| Dermoid Cyst | 2 | 1990 | 12 | 0.110 |
Why?
| Diagnosis, Differential | 7 | 2002 | 1357 | 0.110 |
Why?
| Portography | 5 | 2000 | 13 | 0.110 |
Why?
| Radiopharmaceuticals | 2 | 2011 | 187 | 0.110 |
Why?
| Esophageal Neoplasms | 1 | 1997 | 273 | 0.110 |
Why?
| Cysts | 1 | 1994 | 93 | 0.110 |
Why?
| Colorectal Neoplasms | 4 | 2009 | 617 | 0.110 |
Why?
| Bile Ducts, Intrahepatic | 3 | 2000 | 49 | 0.110 |
Why?
| Radio Waves | 1 | 2013 | 16 | 0.110 |
Why?
| Linear Models | 2 | 2013 | 776 | 0.110 |
Why?
| Information Services | 1 | 2013 | 46 | 0.110 |
Why?
| Social Networking | 1 | 2013 | 31 | 0.110 |
Why?
| Industry | 1 | 2013 | 65 | 0.100 |
Why?
| Thoracic Diseases | 1 | 1992 | 13 | 0.100 |
Why?
| Planning Techniques | 1 | 2012 | 13 | 0.100 |
Why?
| Retrospective Studies | 15 | 2007 | 12608 | 0.100 |
Why?
| Transplantation | 1 | 1992 | 23 | 0.100 |
Why?
| Lymphoproliferative Disorders | 1 | 1992 | 46 | 0.100 |
Why?
| Rhenium | 1 | 2011 | 9 | 0.100 |
Why?
| Radiation Protection | 1 | 2012 | 35 | 0.100 |
Why?
| Educational Measurement | 1 | 2013 | 262 | 0.100 |
Why?
| Data Collection | 1 | 2014 | 636 | 0.090 |
Why?
| Antibiotics, Antineoplastic | 1 | 2011 | 114 | 0.090 |
Why?
| Radiation Dosage | 1 | 2012 | 139 | 0.090 |
Why?
| Varicose Veins | 1 | 1991 | 14 | 0.090 |
Why?
| Alberta | 1 | 2010 | 10 | 0.090 |
Why?
| Neoplasm Staging | 2 | 1995 | 1178 | 0.090 |
Why?
| Vascular Diseases | 2 | 2004 | 230 | 0.090 |
Why?
| Orbit | 1 | 1991 | 59 | 0.090 |
Why?
| Education, Continuing | 1 | 2010 | 40 | 0.090 |
Why?
| Liposarcoma | 1 | 1990 | 26 | 0.090 |
Why?
| Documentation | 1 | 2012 | 169 | 0.090 |
Why?
| Therapy, Computer-Assisted | 1 | 2010 | 58 | 0.090 |
Why?
| Forensic Medicine | 1 | 1990 | 16 | 0.090 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2012 | 220 | 0.090 |
Why?
| Hospitals, Teaching | 1 | 2010 | 103 | 0.090 |
Why?
| Diaphragm | 2 | 2007 | 33 | 0.090 |
Why?
| Combined Modality Therapy | 3 | 2011 | 1127 | 0.090 |
Why?
| Leadership | 1 | 2013 | 302 | 0.090 |
Why?
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 100 | 0.090 |
Why?
| ROC Curve | 2 | 2005 | 451 | 0.080 |
Why?
| Physicians | 1 | 2017 | 776 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2010 | 119 | 0.080 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 1198 | 0.080 |
Why?
| Professional-Patient Relations | 1 | 2010 | 143 | 0.080 |
Why?
| Oxygen Radioisotopes | 1 | 2008 | 3 | 0.080 |
Why?
| Patient Selection | 2 | 2004 | 654 | 0.080 |
Why?
| Kidney | 3 | 1993 | 1207 | 0.080 |
Why?
| Sigmoid Diseases | 2 | 1999 | 10 | 0.080 |
Why?
| Mesentery | 2 | 1999 | 53 | 0.080 |
Why?
| Iopamidol | 4 | 1995 | 13 | 0.070 |
Why?
| Shoulder Pain | 1 | 2007 | 33 | 0.070 |
Why?
| Positron-Emission Tomography | 1 | 2008 | 284 | 0.070 |
Why?
| Wounds, Gunshot | 1 | 1990 | 187 | 0.070 |
Why?
| Computer Communication Networks | 1 | 2006 | 32 | 0.070 |
Why?
| Colorado | 2 | 2013 | 4113 | 0.070 |
Why?
| Rats, Nude | 3 | 2011 | 27 | 0.070 |
Why?
| Clinical Trials as Topic | 3 | 2009 | 941 | 0.070 |
Why?
| Liver Diseases | 3 | 1996 | 263 | 0.070 |
Why?
| Chills | 1 | 2005 | 2 | 0.060 |
Why?
| Antineoplastic Agents | 2 | 2010 | 1893 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2015 | 1829 | 0.060 |
Why?
| Colon | 2 | 2004 | 234 | 0.060 |
Why?
| Syndrome | 1 | 2005 | 339 | 0.060 |
Why?
| Aged, 80 and over | 6 | 2007 | 6417 | 0.060 |
Why?
| Abdominal Neoplasms | 1 | 2004 | 26 | 0.060 |
Why?
| Fever | 1 | 2005 | 280 | 0.060 |
Why?
| Adolescent | 9 | 2004 | 17889 | 0.060 |
Why?
| Laser Therapy | 2 | 2003 | 99 | 0.060 |
Why?
| Follow-Up Studies | 4 | 2005 | 4440 | 0.060 |
Why?
| Education, Medical, Graduate | 1 | 2007 | 376 | 0.060 |
Why?
| Models, Biological | 1 | 2010 | 1646 | 0.060 |
Why?
| Predictive Value of Tests | 3 | 2000 | 1805 | 0.060 |
Why?
| Radiographic Image Enhancement | 2 | 2000 | 58 | 0.050 |
Why?
| Retroperitoneal Space | 2 | 1999 | 15 | 0.050 |
Why?
| Stents | 2 | 1997 | 475 | 0.050 |
Why?
| Cholecystostomy | 1 | 2001 | 4 | 0.050 |
Why?
| Cholecystitis | 1 | 2001 | 17 | 0.050 |
Why?
| Suction | 1 | 2001 | 31 | 0.050 |
Why?
| Multiple Trauma | 1 | 2001 | 90 | 0.050 |
Why?
| Feasibility Studies | 2 | 2003 | 741 | 0.050 |
Why?
| Pelvic Neoplasms | 1 | 2000 | 19 | 0.040 |
Why?
| Cholecystography | 1 | 2000 | 2 | 0.040 |
Why?
| Cystic Duct | 1 | 2000 | 3 | 0.040 |
Why?
| Hepatic Duct, Common | 1 | 2000 | 5 | 0.040 |
Why?
| Diathermy | 1 | 2000 | 2 | 0.040 |
Why?
| Common Bile Duct | 1 | 2000 | 14 | 0.040 |
Why?
| Models, Animal | 2 | 2012 | 350 | 0.040 |
Why?
| Cholecystectomy | 1 | 2000 | 45 | 0.040 |
Why?
| Stomach | 1 | 2000 | 101 | 0.040 |
Why?
| Liver Regeneration | 1 | 1999 | 32 | 0.040 |
Why?
| Laser Coagulation | 1 | 2000 | 54 | 0.040 |
Why?
| Omentum | 1 | 1999 | 8 | 0.040 |
Why?
| Artifacts | 1 | 2000 | 122 | 0.040 |
Why?
| Embolization, Therapeutic | 1 | 2001 | 179 | 0.040 |
Why?
| False Negative Reactions | 1 | 1999 | 50 | 0.040 |
Why?
| Algorithms | 3 | 2010 | 1490 | 0.040 |
Why?
| Neoplasm Transplantation | 2 | 2010 | 235 | 0.040 |
Why?
| Image Enhancement | 1 | 2000 | 173 | 0.040 |
Why?
| Portal System | 2 | 1995 | 13 | 0.040 |
Why?
| Edema | 1 | 1999 | 119 | 0.040 |
Why?
| Perioperative Care | 1 | 1999 | 126 | 0.040 |
Why?
| Risk Assessment | 1 | 2007 | 2987 | 0.040 |
Why?
| Iothalamate Meglumine | 2 | 1996 | 3 | 0.040 |
Why?
| Neoplastic Cells, Circulating | 2 | 1996 | 59 | 0.040 |
Why?
| Analysis of Variance | 2 | 2011 | 1227 | 0.040 |
Why?
| Anesthesia | 1 | 1999 | 119 | 0.040 |
Why?
| Rats | 3 | 2011 | 5034 | 0.040 |
Why?
| Administration, Oral | 1 | 2000 | 734 | 0.040 |
Why?
| Adenocarcinoma | 1 | 2004 | 799 | 0.040 |
Why?
| Bile Ducts, Extrahepatic | 1 | 1997 | 25 | 0.040 |
Why?
| Ureteral Obstruction | 2 | 1994 | 54 | 0.040 |
Why?
| Intestines | 1 | 2000 | 324 | 0.040 |
Why?
| Appendix | 1 | 1997 | 26 | 0.030 |
Why?
| Punctures | 1 | 1996 | 37 | 0.030 |
Why?
| Kidney Diseases | 2 | 2004 | 354 | 0.030 |
Why?
| Neoplasm Recurrence, Local | 1 | 2001 | 863 | 0.030 |
Why?
| Ascites | 1 | 1996 | 35 | 0.030 |
Why?
| Colonic Polyps | 1 | 1997 | 67 | 0.030 |
Why?
| Drainage | 1 | 1996 | 151 | 0.030 |
Why?
| Regional Blood Flow | 2 | 2003 | 414 | 0.030 |
Why?
| Injections, Intravenous | 2 | 2010 | 204 | 0.030 |
Why?
| Pulsatile Flow | 1 | 1995 | 54 | 0.030 |
Why?
| Appendicitis | 1 | 1997 | 108 | 0.030 |
Why?
| Triiodobenzoic Acids | 3 | 2001 | 12 | 0.030 |
Why?
| Radionuclide Imaging | 2 | 2011 | 121 | 0.030 |
Why?
| Multivariate Analysis | 1 | 1999 | 1440 | 0.030 |
Why?
| Colic | 1 | 1994 | 6 | 0.030 |
Why?
| Vascular Patency | 1 | 1995 | 97 | 0.030 |
Why?
| Risk | 1 | 2017 | 819 | 0.030 |
Why?
| Peripheral Vascular Diseases | 1 | 1995 | 98 | 0.030 |
Why?
| Cholangiocarcinoma | 1 | 1994 | 38 | 0.030 |
Why?
| Gastrointestinal Hemorrhage | 1 | 1995 | 102 | 0.030 |
Why?
| Bile Duct Neoplasms | 1 | 1994 | 56 | 0.030 |
Why?
| Systole | 1 | 1994 | 169 | 0.030 |
Why?
| Population Surveillance | 1 | 1997 | 395 | 0.030 |
Why?
| Hyperthermia, Induced | 2 | 2005 | 65 | 0.030 |
Why?
| Vascular Resistance | 1 | 1994 | 338 | 0.030 |
Why?
| Pilot Projects | 1 | 2017 | 1377 | 0.030 |
Why?
| Recurrence | 1 | 1996 | 952 | 0.030 |
Why?
| Hemangioendothelioma | 1 | 1992 | 12 | 0.030 |
Why?
| NADPH Dehydrogenase | 1 | 2012 | 8 | 0.030 |
Why?
| Risk Factors | 4 | 2007 | 8697 | 0.030 |
Why?
| Nuclear Medicine | 1 | 2011 | 7 | 0.020 |
Why?
| Tromethamine | 1 | 2011 | 2 | 0.020 |
Why?
| Staining and Labeling | 1 | 2012 | 139 | 0.020 |
Why?
| Isotope Labeling | 1 | 2011 | 76 | 0.020 |
Why?
| Transplantation, Heterologous | 1 | 2011 | 187 | 0.020 |
Why?
| Data Interpretation, Statistical | 1 | 1993 | 324 | 0.020 |
Why?
| Drug Synergism | 1 | 2011 | 317 | 0.020 |
Why?
| Acute Disease | 3 | 2001 | 914 | 0.020 |
Why?
| Random Allocation | 1 | 2011 | 337 | 0.020 |
Why?
| Finite Element Analysis | 1 | 2010 | 69 | 0.020 |
Why?
| Liposomes | 1 | 2011 | 149 | 0.020 |
Why?
| Technetium Tc 99m Pentetate | 1 | 2010 | 7 | 0.020 |
Why?
| Chemotherapy, Adjuvant | 1 | 2011 | 334 | 0.020 |
Why?
| Infant | 2 | 1994 | 7979 | 0.020 |
Why?
| Child, Preschool | 2 | 1994 | 9133 | 0.020 |
Why?
| Materials Testing | 1 | 2011 | 356 | 0.020 |
Why?
| Tissue Distribution | 1 | 2010 | 324 | 0.020 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 106 | 0.020 |
Why?
| Swine | 1 | 2011 | 704 | 0.020 |
Why?
| Health Status Disparities | 1 | 2009 | 204 | 0.020 |
Why?
| Efficiency | 1 | 2007 | 84 | 0.020 |
Why?
| Personnel Selection | 1 | 2007 | 67 | 0.020 |
Why?
| Glucose | 1 | 2011 | 904 | 0.020 |
Why?
| Heart Transplantation | 1 | 1992 | 671 | 0.020 |
Why?
| Hemorrhage | 2 | 2004 | 618 | 0.020 |
Why?
| Child | 3 | 1994 | 18488 | 0.020 |
Why?
| Surveys and Questionnaires | 1 | 2017 | 4665 | 0.020 |
Why?
| Lasers | 1 | 2005 | 121 | 0.020 |
Why?
| Models, Statistical | 1 | 2008 | 606 | 0.020 |
Why?
| Prognosis | 1 | 1992 | 3339 | 0.010 |
Why?
| Medical Records | 1 | 2005 | 157 | 0.010 |
Why?
| Adrenal Gland Diseases | 1 | 2004 | 6 | 0.010 |
Why?
| Neoplasm Seeding | 1 | 2004 | 7 | 0.010 |
Why?
| Intestinal Obstruction | 1 | 2004 | 41 | 0.010 |
Why?
| Intestinal Perforation | 1 | 2004 | 38 | 0.010 |
Why?
| Ultrasonic Therapy | 1 | 2003 | 10 | 0.010 |
Why?
| Cryotherapy | 1 | 2003 | 16 | 0.010 |
Why?
| Hot Temperature | 1 | 2005 | 303 | 0.010 |
Why?
| Gallbladder | 1 | 2003 | 14 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2011 | 3580 | 0.010 |
Why?
| Incidence | 1 | 2007 | 2335 | 0.010 |
Why?
| Venous Pressure | 1 | 2000 | 8 | 0.010 |
Why?
| Burns | 1 | 2004 | 242 | 0.010 |
Why?
| Jejunum | 1 | 2000 | 24 | 0.010 |
Why?
| Postanesthesia Nursing | 1 | 1999 | 2 | 0.010 |
Why?
| Duodenum | 1 | 2000 | 63 | 0.010 |
Why?
| Ileum | 1 | 2000 | 93 | 0.010 |
Why?
| Equipment Failure | 1 | 2000 | 109 | 0.010 |
Why?
| Peritoneal Diseases | 1 | 1999 | 4 | 0.010 |
Why?
| Single-Blind Method | 1 | 2000 | 255 | 0.010 |
Why?
| Confidence Intervals | 1 | 2000 | 309 | 0.010 |
Why?
| Observer Variation | 1 | 2000 | 297 | 0.010 |
Why?
| Statistics as Topic | 1 | 2000 | 299 | 0.010 |
Why?
| Comorbidity | 1 | 2001 | 1473 | 0.010 |
Why?
| Contraindications | 1 | 1996 | 86 | 0.010 |
Why?
| Abdomen | 1 | 1996 | 104 | 0.010 |
Why?
| Hematocrit | 1 | 1996 | 86 | 0.010 |
Why?
| Heart Failure | 1 | 1988 | 1963 | 0.010 |
Why?
| Pelvis | 1 | 1996 | 92 | 0.010 |
Why?
| Needles | 1 | 1996 | 52 | 0.010 |
Why?
| Lymphatic Metastasis | 1 | 1996 | 276 | 0.010 |
Why?
| Hemodynamics | 1 | 2000 | 968 | 0.010 |
Why?
| Reference Values | 1 | 1997 | 744 | 0.010 |
Why?
| Injections, Intra-Arterial | 1 | 1994 | 25 | 0.010 |
Why?
| Splenic Artery | 1 | 1994 | 12 | 0.010 |
Why?
| Mesenteric Artery, Superior | 1 | 1994 | 11 | 0.010 |
Why?
| Urography | 1 | 1994 | 13 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1995 | 169 | 0.010 |
Why?
| False Positive Reactions | 1 | 1995 | 109 | 0.010 |
Why?
| Pentetic Acid | 1 | 1993 | 12 | 0.010 |
Why?
| Hemoglobins | 1 | 1996 | 312 | 0.010 |
Why?
| Meglumine | 1 | 1993 | 13 | 0.010 |
Why?
| Osmolar Concentration | 1 | 1994 | 178 | 0.010 |
Why?
| Gadolinium DTPA | 1 | 1993 | 52 | 0.010 |
Why?
| Blood Transfusion | 1 | 1996 | 277 | 0.010 |
Why?
| Catheterization, Peripheral | 1 | 1994 | 102 | 0.010 |
Why?
| Gadolinium | 1 | 1993 | 78 | 0.010 |
Why?
| Adenoma, Bile Duct | 1 | 1992 | 1 | 0.010 |
Why?
| Drug Combinations | 1 | 1993 | 289 | 0.010 |
Why?
| Organometallic Compounds | 1 | 1993 | 102 | 0.010 |
Why?
| Hydronephrosis | 1 | 1992 | 28 | 0.010 |
Why?
| Graft Survival | 1 | 1993 | 480 | 0.010 |
Why?
| Case-Control Studies | 1 | 1996 | 3022 | 0.010 |
Why?
| Kidney Neoplasms | 1 | 1993 | 326 | 0.000 |
Why?
| Biopsy | 1 | 1992 | 1056 | 0.000 |
Why?
|
|
Dodd's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|